<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Presently, no markers exist to predict metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> at the time a primary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is diagnosed </plain></SENT>
<SENT sid="1" pm="."><plain>While <z:mp ids='MP_0004024'>aneuploidy</z:mp> indicates poor survival prognosis and elevated carcinoembryonic antigen (CEA) levels the presence of <z:e sem="disease" ids="C0277556" disease_type="Disease or Syndrome" abbrv="">recurrent disease</z:e>, the predictive value of both markers regarding imminent metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> is unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Sixty patients with distant recurrence throughout a 5-year follow-up (TM+) were randomly chosen and 60 patients without <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> matched to this cohort (TM-) </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, an enlarged collective (n = 217; n (TM+) = 85, n (TM-) = 132) with median follow-up of 79.2 months was assessed by logistic regression regarding metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Univariate and stepwise regression analyses included clinicopathological characteristics, preoperative CEA levels and <z:mp ids='MP_0004024'>aneuploidy</z:mp> assessed by DNA image cytometry </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The matched-pair collective showed <z:mp ids='MP_0004024'>aneuploidy</z:mp> in 71.1 % (TM-) and 85.0 % (TM+; p = 0.076), and elevated CEA in 24.5 % (TM-) and 52.2 % [TM+; odds ratio (OR), 3.414; p = 0.007] </plain></SENT>
<SENT sid="6" pm="."><plain>The enlarged collective presented <z:mp ids='MP_0004024'>aneuploidy</z:mp> in 71.2 % (TM-) and 83.5 % (TM+; OR 2.050, p = 0.038), and elevated CEA in 28.6 % (TM-) and 48.9 % (TM+; OR 2.391, p = 0.020) </plain></SENT>
<SENT sid="7" pm="."><plain>Elevated CEA and <z:mp ids='MP_0004024'>aneuploidy</z:mp> did not show any association (p = 0.919) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, logistic regression analyses demonstrated that besides increased T category (OR 1.745, p = 0.019), both elevated CEA level (OR 2.633, p = 0.015) and <z:mp ids='MP_0004024'>aneuploidy</z:mp> (OR 1.929, p = 0.058) were independent predictive markers for metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Our data show that <z:mp ids='MP_0004024'>aneuploidy</z:mp> and elevated CEA levels besides increased T category could serve for individual risk assessment to predict metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The fact that still <z:mp ids='MP_0004024'>aneuploidy</z:mp> missed the significance level by a small margin emphasizes the need for larger validation studies </plain></SENT>
</text></document>